• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Nomura Phase4 Ventures

edit

Phase4 Ventures is a global life science investor whose mission is to provide a premium rate of return for investors by creating, identifying and investing in development stage healthcare companies through its dedicated fund. Phase4 Ventures invests in biopharma, specialty pharmaceutical and medical device companies in the US and Europe.

Milestones

edit

• 
  Nomura Phase4 Ventures invested in Chroma Therapeutics. (4/3/06)
  Posted 4/19/10 at 9:38pm via chromatherapeutics.com
• 
  Nomura Phase4 Ventures invested in OncoMed Pharmaceuticals. (11/4/08)
  Posted 4/19/10 at 7:01pm via biospace.com
• 
  Nomura Phase4 Ventures invested in Phenomix. (3/8/07)
  Posted 3/10/10 at 9:53pm via phenomixcorp.com
• 
  Nomura Phase4 Ventures invested in Zosano Pharma. (8/6/09)
  Posted 8/6/09 at 10:23am via onbiovc.com
• 
  Nomura Phase4 Ventures invested in Zosano Pharma. (11/15/07)
  Posted 7/14/09 at 3:46am via zosanopharma.com

Investments

Videos

Sources

1. Zosano Pharma, Inc.: Series B $30M (onbiovc.com) [edit]
2. OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing (biospace.com) [edit]
3. Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com) [edit]
4. PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING (phenomixcorp.com) [edit]
5. CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING (chromatherapeutics.com) [edit]